All articles

Spine Health · September 22, 2026

Emerging Biological Treatments for Back Pain: What You Need to Know About Stem Cell Therapy

By Dr. Dwight S. Tyndall, MD, FAAOS

For decades, the standard treatment path for persistent back pain followed a familiar sequence: conservative care (physical therapy, medications, and targeted injections), followed by surgical intervention if pain persisted. Today, advances in regenerative medicine are introducing a promising middle ground: biological therapies designed to support tissue health and reduce inflammation at the cellular level.

Among these emerging options, stem cell injections are generating significant interest from patients seeking non-surgical relief for chronic spinal conditions.

Understanding Biological Therapies in Spine Care

Biological treatments — often referred to as regenerative medicine — utilize naturally occurring cells, signaling proteins, or growth factors to modulate inflammation and stimulate localized tissue repair. Rather than simply masking symptoms, biological therapies aim to improve the microenvironment within damaged spinal tissues.

In spine care, biological treatments are primarily explored for two conditions:

How Stem Cell Injections Work

Stem cells are unique because they release signaling molecules (cytokines and growth factors) that suppress chronic inflammation and encourage cellular health.

In spinal applications, procedures typically utilize Mesenchymal Stem Cells (MSCs) harvested from the patient’s own body (autologous transfer), most commonly from bone marrow aspirate or adipose (fat) tissue:

Are There Any FDA-Approved Stem Cell Injections for Back Pain?

No — currently, there are no stem cell products or cellular injections approved by the U.S. Food and Drug Administration (FDA) specifically for treating back pain, spinal disc degeneration, or joint arthritis.

While the FDA permits certain procedures using a patient’s own stem cells (autologous bone marrow aspirates) under strict guidelines requiring minimal processing during the same surgical procedure, these are considered investigational or performed off-label. Many clinics offering “off-the-shelf” stem cell or amniotic fluid injections operate without FDA approval for spine conditions. Because these therapies remain investigational, insurance typically does not cover them, making it essential for patients to evaluate commercial claims critically.

Current Evidence and Realistic Expectations

While early-phase clinical trials show promise for pain reduction in select patients, understanding what biological treatments can and cannot do is crucial:

Navigating Your Options Safely

Biological spine care is an evolving field that holds genuine long-term potential, but it must be approached with realistic expectations and clinical rigor.

If you are considering stem cell or biological therapy for chronic back pain, consult with a board-certified spine specialist. A thorough clinical evaluation — including up-to-date MRI imaging and a physical examination — will help determine whether a biological approach, traditional conservative care, or surgical intervention offers the highest likelihood of lasting relief.

Questions about stem cell or biological treatments?

Dr. Tyndall sees patients at his Crown Point and Schererville offices.

Call (219) 250-5035